Analyst Rating Changes — Upgrades, Downgrades & Price Targets

40803 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.

Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.

All ↑ Upgrades ↓ Downgrades ◎ Price Targets

Latest Price-Target Changes

When	Stock	Change	Firm	Analyst	Rating	Price Target
Sep 10 00:58 UTC	QCOM Qualcomm	◎ Target	Royal Bank Of Canada	Srini Pajjuri ★★★☆☆ #1440	Sec→ r Perform	$160.00→ $180.00+12.5%
Sep 10 00:58 UTC	PYXS Pyxis Oncology	◎ Target	Wells Fargo & Company	Derek Archila ★★★☆☆ #2257	Overweight	$12.00→ $19.00+58.3%
Sep 10 00:58 UTC	POR Portland General Electric	◎ Target	JPMorgan Chase & Co.	Aidan Kelly ★★★☆☆ #1301	Neutral	$56.00→ $53.00-5.4%
Sep 10 00:58 UTC	PLCE Children's Place	◎ Target	UBS Group	Jay Sole ★★★☆☆ #1961	Neutral	$4.00→ $3.25-18.8%
Sep 10 00:58 UTC	PII Polaris	◎ Target	Citigroup	James Hardiman ★★☆☆☆ #2616	Neutral	$73.00→ $67.00-8.2%
Sep 10 00:58 UTC	PHVS Pharvaris	◎ Target	Morgan Stanley	Maxwell Skor ★★★☆☆ #2100	Overweight	$46.00→ $62.00+34.8%
Sep 10 00:58 UTC	PHVS Pharvaris	◎ Target	Leerink Partners	Joseph Schwartz ★★★☆☆ #2172	Outperform	$50.00→ $65.00+30.0%
Sep 10 00:58 UTC	PHVS Pharvaris	◎ Target	Wells Fargo & Company	Yanan Zhu ★★★☆☆ #2261	Overweight	$55.00→ $65.00+18.2%
Sep 10 00:58 UTC	PHVS Pharvaris	◎ Target	Citizens Jmp	Jonathan Wolleben ★★☆☆☆ #2558	Market Outperform	$75.00→ $79.00+5.3%
Sep 10 00:58 UTC	PHVS Pharvaris	◎ Target	Royal Bank Of Canada	Nevin Varghese not yet tracked	Outperform	$52.00→ $62.00+19.2%
Sep 10 00:58 UTC	PDM Piedmont Realty Trust	◎ Target	JPMorgan Chase & Co.	Anthony Paolone ★★★☆☆ #1303	Neutral	$10.00→ $11.00+10.0%
Sep 10 00:58 UTC	PAYX Paychex	◎ Target	Wells Fargo & Company	Jason Kupferberg ★★★★☆ #934	Underweight	$95.00→ $111.00+16.8%
Sep 10 00:58 UTC	PAYX Paychex	◎ Target	Stifel Nicolaus	David Grossman ★★★★★ #92	Hold	$110.00→ $130.00+18.2%
Sep 10 00:58 UTC	PAGE PageGroup	◎ Target	Deutsche Bank Aktiengesellschaft	firm only	Buy	GBX 210→ GBX 355+69.0%
Sep 10 00:58 UTC	ORCL Oracle	◎ Target	Scotiabank	Patrick Colville ★★★★★ #57	Sec→ r Outperform	$241.00→ $215.00-10.8%
Sep 10 00:58 UTC	ORA Ormat Technologies	◎ Target	JPMorgan Chase & Co.	Mark Strouse ★☆☆☆☆ #3007	Neutral	$122.00→ $131.00+7.4%
Sep 10 00:58 UTC	ORA Ormat Technologies	◎ Target	Oppenheimer	Noah Kaye ★★☆☆☆ #2276	Outperform	$141.00→ $145.00+2.8%
Sep 10 00:58 UTC	OKE ONEOK	◎ Target	Morgan Stanley	Robert Kad ★★★★☆ #895	Equal Weight	$105.00→ $112.00+6.7%
Sep 10 00:58 UTC	OGE OGE Energy	◎ Target	JPMorgan Chase & Co.	Aidan Kelly ★★★☆☆ #1301	Overweight	$55.00→ $54.00-1.8%
Sep 10 00:58 UTC	ODD ODDITY Tech	◎ Target	Jefferies Financial Group	Brian Tanquilut ★★★☆☆ #1870	Hold	$16.00→ $18.00+12.5%
Sep 10 00:58 UTC	NWE NorthWestern	◎ Target	JPMorgan Chase & Co.	Aidan Kelly ★★★☆☆ #1301	Neutral	$76.00→ $73.00-3.9%
Sep 10 00:58 UTC	NUE Nucor	◎ Target	JPMorgan Chase & Co.	Bennett Moore ★★★☆☆ #2037	Overweight	$294.00→ $308.00+4.8%
Sep 10 00:58 UTC	NTRA Natera	◎ Target	UBS Group	Doug Schenkel not yet tracked	Buy	$290.00→ $435.00+50.0%
Sep 10 00:58 UTC	NTLA Intellia Therapeutics	◎ Target	Wedbush	David Nierengarten ★★★☆☆ #2205	Neutral	$12.00→ $13.00+8.3%
Sep 10 00:58 UTC	NEM Newmont	◎ Target	Sanford C. Bernstein	Bob Brackett ★★★☆☆ #1423	Outperform	$147.00→ $144.00-2.0%
Sep 10 00:58 UTC	MRVI Maravai LifeSciences	◎ Target	UBS Group	Dan Brennan not yet tracked	Neutral	$2.50→ $8.00+220.0%
Sep 10 00:58 UTC	MRK Merck & Co., Inc.	◎ Target	Leerink Partners	Daina Graybosch ★★★☆☆ #1376	Outperform	$127.00→ $161.00+26.8%
Sep 10 00:58 UTC	MAB1 Mortgage Advice Bureau	◎ Target	Berenberg Bank	firm only	Buy	GBX 1,150→ GBX 975-15.2%
Sep 10 00:58 UTC	LULU lululemon athletica	◎ Target	Citigroup	Paul Lejuez ★★★☆☆ #1189	Neutral	$130.00→ $117.00-10.0%
Sep 10 00:58 UTC	LOW Lowe's Companies	◎ Target	Sanford C. Bernstein	Zhihan Ma ★★★★☆ #521	Outperform	$261.00→ $254.00-2.7%
Sep 10 00:58 UTC	LFST LifeStance Health Group	◎ Target	Canaccord Genuity Group	Richard Close ★★★★★ #159	Buy	$13.00→ $15.00+15.4%
Sep 10 00:58 UTC	KNF Knife River	◎ Target	Wells Fargo & Company	Timna Tanners ★★★☆☆ #1842	Equal Weight	$73.00→ $62.00-15.1%
Sep 10 00:58 UTC	JSG Johnson Service Group	◎ Target	Berenberg Bank	firm only	Buy	GBX 205→ GBX 200-2.4%
Sep 10 00:58 UTC	JILL J.Jill	◎ Target	BTIG Research	Janine Stichter ★★★☆☆ #1360	Buy	$18.00→ $25.00+38.9%
Sep 10 00:58 UTC	IVN Ivanhoe Mines	◎ Target	Scotia	firm only	Sec→ r Perform	C$13.00→ C$13.50+3.8%
Sep 10 00:58 UTC	IVN Ivanhoe Mines	◎ Target	Canaccord Genuity Group	firm only	Buy	C$13.00→ C$15.00+15.4%
Sep 10 00:58 UTC	IVN Ivanhoe Mines	◎ Target	Stifel Nicolaus	firm only	Buy	C$15.00→ C$17.00+13.3%
Sep 10 00:58 UTC	IRD Opus Genetics	◎ Target	Chardan Capital	Andreas Argyrides ★☆☆☆☆ #3167	Buy	$13.00→ $16.00+23.1%
Sep 10 00:58 UTC	IRD Opus Genetics	◎ Target	Oppenheimer	Andreas Argyrides ★☆☆☆☆ #3167	Outperform	$10.00→ $20.00+100.0%
Sep 10 00:58 UTC	IONS Ionis Pharmaceuticals	◎ Target	Barclays	Eliana Merle ★★★☆☆ #1395	Overweight	$90.00→ $85.00-5.6%
Sep 10 00:58 UTC	IONQ IonQ	◎ Target	Mizuho	Vijay Rakesh ★★★☆☆ #2082	Outperform	$61.00→ $52.00-14.8%
Sep 10 00:58 UTC	INNV InnovAge	◎ Target	KeyCorp	Matthew Gillmor not yet tracked	Overweight	$13.00→ $14.00+7.7%
Sep 10 00:58 UTC	IMAX IMAX	◎ Target	Rosenblatt Securities	Steve Frankel ★★★☆☆ #2051	Buy	$60.00→ $65.00+8.3%
Sep 10 00:58 UTC	IEX IDEX	◎ Target	Oppenheimer	Bryan Blair ★★★☆☆ #1452	Outperform	$265.00→ $270.00+1.9%
Sep 10 00:58 UTC	IDYA IDEAYA Biosciences	◎ Target	Guggenheim	Paul Jeng ★☆☆☆☆ #3132	Buy	$54.00→ $57.00+5.6%
Sep 10 00:58 UTC	HOOD Robinhood Markets	◎ Target	Mizuho	Dan Dolev ★★★☆☆ #1969	Outperform	$130.00→ $140.00+7.7%
Sep 10 00:58 UTC	HLN Haleon	◎ Target	Deutsche Bank Aktiengesellschaft	firm only	Sell	GBX 335→ GBX 320-4.5%
Sep 10 00:58 UTC	HD Home Depot	◎ Target	Sanford C. Bernstein	Zhihan Ma ★★★★☆ #521	Market Perform	$354.00→ $344.00-2.8%
Sep 10 00:58 UTC	HASI HA Sustainable Infrastructure Capital	◎ Target	Mizuho	Maheep Mandloi ★☆☆☆☆ #3086	Outperform	$41.00→ $50.00+22.0%
Sep 10 00:58 UTC	HAS Hays	◎ Target	Deutsche Bank Aktiengesellschaft	firm only	Buy	GBX 60→ GBX 95+58.3%

🔒 38 more rating changes on this page — plus filtering by our own analyst accuracy.

A free account unlocks the full daily feed.

Frequently Asked Questions

What are analyst rating changes?

An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.

How is this feed different from other rating trackers?

Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.

How often is the rating-changes feed updated?

The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.

Do analyst upgrades and price-target increases mean I should buy?

No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.

Analyst Rating Changes — Upgrades, Downgrades & Price Targets

Latest Price-Target Changes

Frequently Asked Questions

Welcome to 13Foresight!